RBMXL3
RNA-binding motif protein, X-linked-like-3
Also known as: CXorf55, FLJ40249, RMXL3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N7X1
- Gene
- RBMXL3
- Ensembl
- ENSG00000175718
- Chromosome
- X
- Canonical length
- 1067 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1067 residues, UniProt reviewed canonical sequence.
>Q8N7X1|RBMXL3
1 MMEADRPEKL FIGGLNLKTD EKALKAEFGK YGHIIKVFLM KDRKTNKSRG FAFVTFESPA
61 DAKAAARDMN GKYLDGKAIM VAQTIKPAFK SSRWVPPTPG SGSRSRFSHR TRGGGSSPQR
121 PPSQGRPDDG RGYAGYFDLW PYRAPMPRKR GPPPRHWASP PHKRATPSSL AHSVGCGMRG
181 KAPTVSGQDG YSGLQPRRWA GPPHKRAVPR SSLARIGGSG MPGKAPAVWG QDGYSGPRVR
241 EPLPPCRDPG DFVPALRDYS RRYYGHSSVP DYRPLRGDGN QNGYRGRDHE YTDHPSKGSY
301 REPLKSYGGP CGAAPVWGTP PSYGGGCRYE EYQGNSPDAC SEGRSSEALP VVLPDAYSRD
361 HSPKAYSGGR SSSSNGYSRS DRYGEEGCYE EYRGRSPDAH SGGRNSSSNS YGQSHHYGGE
421 GRYEEYRGRS HEARSGGRST DAHSRGRSDD AYSGGHDSSS WSDCCGGGGR YEEYQGRSLD
481 ANSGGCSPEA YSGGHDNSSW SDRYGVGGHY EENRGHSLDA NSGGRSPDTH SGGHSSSSNS
541 YGQSHRYGGE GRYEYRGRSH DAHSGGCSAD AYSGGHDSSS QSNRYGGGGC YEEYRGRSLD
601 ANSGGRSPNA YSGGHDSSSW SHRYGGGGRY EEYRGRSLDA NSGGRSPDAY SGGHDSSGQS
661 NCYGGGGRYE EYRGRLLDAN SGGRSPDAYS GGHDSSSQSN RYGGGGRYEE YRGHSLDANS
721 GGRSPDTYSR GHDSSSQSDH YGGGGRSLDA NSSGRLPDAY SGGHDSSSRS HRYGGGGRYE
781 EYRGRSLDAN SGGRSPNAYS GGHNSSSRND PCRGGGRYEE NRGHSLDANS GGHSPNAYSG
841 GRDSSSNSYD RSHRYGGGGH YEEYRGRSHD THSRGRSPDA HSGDHYTEAY SRGRDSFSNS
901 YGRSDHYGRG GCYEEYQGRS PNAYGGGRGL NSSNNSHGRS HRYGGGGRYE EYRGPSPDAH
961 SGGRDSSIKS YGLSDRYGGG GHYEEYQGSL PDAYSGDHDR SSNSYGRSDR YSRGRDRVGR
1021 PDRGLPLPME TGSPPLHDSY SRSGCRVPRG GGRQGGRFER GEGRSRYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBMXL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 2.6 nTPM
Expression across tissuesHPA
Tissue
- testis: 2.6 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
Single-cell type
- early primary spermatocytes: 26 nCPM
- differentiating spermatogonia: 16 nCPM
- undifferentiated spermatogonia: 5.3 nCPM
- epicardial cells: 2.3 nCPM
- late spermatids: 0.7 nCPM
- hematopoietic stem cells: 0.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 1.4 nTPM
- white matter: 1.2 nTPM
- cerebral cortex: 1 nTPM
- medulla oblongata: 1 nTPM
- basal ganglia: 0.9 nTPM
- pons: 0.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -0.84
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- via spliceosome
- mRNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBMXL3 as an antibody target. Whether an autoantibody or antibody against RBMXL3 could matter depends on whether native RBMXL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBMXL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBMXL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...